Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
Ryan J. Jalleh, Christopher K. Rayner, Trygve Hausken, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 10, pp. 957-964
Closed Access | Times Cited: 15

Showing 15 citing articles:

Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement
Kariem El‐Boghdadly, Jugdeep Dhesi, Philippa Fabb, et al.
Anaesthesia (2025)
Open Access | Times Cited: 3
Variability in the management of GLP-1 agonists and endoscopic procedures: an opportunity for standardization
Javier Crespo, María Jesús López-Arias, Paula Iruzubieta
Revista Española de Enfermedades Digestivas (2025)
Open Access
Tratamiento actual de la obesidad: una historia sobre creencias, apegos y confrontación
José M. Balibrea, María Recarte-Rico, María Dolores Frutos
Cirugía Española (2025)
Closed Access
Utility of a 13C‐Spirulina Stable Isotope Gastric Emptying Breath Test in Diabetes Mellitus
Revati Varma, Catherine E. Williams, Ethan S. McClain, et al.
Neurogastroenterology & Motility (2025)
Closed Access
Improvement in Helicobacter pylori Eradication Among Adults Receiving Semaglutide: A Population‐Based Propensity‐Score‐Adjusted Analysis
Asaf Ness, Zohar Levi, Rachel Gingold Belfer, et al.
Helicobacter (2025) Vol. 30, Iss. 1
Open Access
Comparison of the efficacy and safety of GLP‐1 receptor agonists on cardiovascular events and risk factors: A review and network meta‐analysis
Xuedong An, WenJie Sun, Zhige Wen, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Otolaryngologic Side Effects of GLP‐1 Receptor Agonists
F. Khan, Sebastian Guadarrama‐Sistos Vazquez, Zain Mehdi, et al.
The Laryngoscope (2025)
Open Access
The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects
Yue Liu, Wei Chen, Xuemei He, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities
Clifford J. Bailey, Peter R. Flatt, J. Michael Conlon
Peptides (2025) Vol. 187, pp. 171380-171380
Open Access
Why are we still in need for novel anti-obesity medications?
Aaron Novikoff, Gerald Grandl, Xue Liu, et al.
The Lancet Regional Health - Europe (2024) Vol. 47, pp. 101098-101098
Closed Access | Times Cited: 2
Semaglutide and the risk of adverse liver outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes: a multi-institutional cohort study
Chia-Chih Kuo, Min‐Hsiang Chuang, Chun‐Hsien Li, et al.
Hepatology International (2024)
Closed Access | Times Cited: 2
The “pandemic” increase of GLP-1 receptor agonists use and the time of discontinuation before anesthesia: Something new?
Luigi Vetrugno, Damiano D’Ardes, Cristian Deana
Journal of Clinical Anesthesia (2024), pp. 111693-111693
Closed Access | Times Cited: 1
Impact of GLP-1 Receptor Agonists in Gastrointestinal Endoscopy: An Updated Review
Sahib Singh, Saurabh Chandan, Dushyant Singh Dahiya, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5627-5627
Open Access | Times Cited: 1
Retrospective review of seven patients with obesity simultaneously treated with a combination of a glucagon-like peptide-1 receptor agonist and a meal replacement product
Catherine Bacus, Terri-Lynne South, Sonia Raudszus, et al.
Obesity Pillars (2024) Vol. 12, pp. 100138-100138
Open Access
GLP-1 receptor agonists and bronchial aspiration risk: what the evidence tells us
Lorenzo Fuccio, Marianna Arvanitakis, Antonio Facciorusso
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 12, pp. 1082-1082
Closed Access
Preoperative Strategies for Patients on Glucagon-like Peptide-1 Receptor Agonists Navigating Current Controversies and Future Directions
Girish P. Joshi
Anesthesiology (2024) Vol. 141, Iss. 6, pp. 1031-1033
Closed Access
Fenugreek gum improves the rheological properties of konjac glucomannan in dynamic simulated digestion system and delays its gastric emptying
Wenjing Chen, An Ding, Shuxin Ye, et al.
International Journal of Biological Macromolecules (2024) Vol. 288, pp. 138713-138713
Closed Access
Page 1

Scroll to top